Lyell Immunopharma Inc (LYEL)
2.47
-0.22
(-8.18%)
USD |
NASDAQ |
May 10, 16:00
2.47
0.00 (0.00%)
After-Hours: 20:00
Lyell Immunopharma Price: 2.47 for May 10, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 09, 2024 | 2.52 | 2.698 | 2.495 | 2.69 | 940308.0 |
May 08, 2024 | 2.55 | 2.58 | 2.47 | 2.50 | 839779.0 |
May 07, 2024 | 2.46 | 2.55 | 2.42 | 2.54 | 926958.0 |
May 06, 2024 | 2.34 | 2.54 | 2.34 | 2.54 | 834542.0 |
May 03, 2024 | 2.44 | 2.66 | 2.35 | 2.36 | 446610.0 |
May 02, 2024 | 2.38 | 2.44 | 2.315 | 2.40 | 799681.0 |
May 01, 2024 | 2.18 | 2.38 | 2.14 | 2.33 | 825231.0 |
Apr 30, 2024 | 2.23 | 2.255 | 2.16 | 2.17 | 560099.0 |
Apr 29, 2024 | 2.19 | 2.275 | 2.19 | 2.25 | 414247.0 |
Apr 26, 2024 | 2.19 | 2.21 | 2.11 | 2.17 | 352183.0 |
Apr 25, 2024 | 2.30 | 2.529 | 2.15 | 2.20 | 540834.0 |
Apr 24, 2024 | 2.42 | 2.48 | 2.29 | 2.30 | 775286.0 |
Apr 23, 2024 | 2.36 | 2.55 | 2.36 | 2.44 | 687131.0 |
Apr 22, 2024 | 2.20 | 2.42 | 2.191 | 2.41 | 958851.0 |
Apr 19, 2024 | 2.31 | 2.38 | 2.15 | 2.23 | 1.080M |
Apr 18, 2024 | 2.33 | 2.415 | 2.26 | 2.33 | 906620.0 |
Apr 17, 2024 | 2.40 | 2.49 | 2.35 | 2.38 | 1.032M |
Apr 16, 2024 | 2.33 | 2.50 | 2.27 | 2.41 | 1.335M |
Apr 15, 2024 | 2.84 | 2.89 | 2.355 | 2.40 | 1.990M |
Apr 12, 2024 | 2.97 | 3.145 | 2.82 | 3.01 | 2.590M |
Apr 11, 2024 | 2.46 | 2.68 | 2.45 | 2.66 | 903555.0 |
Apr 10, 2024 | 2.48 | 2.48 | 2.32 | 2.45 | 1.176M |
Apr 09, 2024 | 2.23 | 2.625 | 2.19 | 2.52 | 1.405M |
Apr 08, 2024 | 2.12 | 2.22 | 2.06 | 2.19 | 496174.0 |
Apr 05, 2024 | 2.07 | 2.14 | 2.01 | 2.09 | 359209.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.39
Minimum
Oct 04 2023
17.95
Maximum
Sep 10 2021
5.584
Average
4.03
Median
May 17 2022
Price Benchmarks
GlycoMimetics Inc | 0.2642 |
Candel Therapeutics Inc | 9.32 |
Eliem Therapeutics Inc | 8.40 |
Entrada Therapeutics Inc | 14.38 |
NovaBay Pharmaceuticals Inc | 0.0804 |
Price Related Metrics
PS Ratio | 9158.75 |
PEG Ratio | -0.1178 |
Price to Book Value | 1.044 |
Earnings Yield | -36.44% |
Market Cap | 629.70M |
PEGY Ratio | -0.1178 |